Complete KALA Stock Valuation Analysis

Comprehensive intrinsic value analysis using 1 different methodologies

KALA Peer Valuation Analysis

Relative valuation based on comparable company trading multiples

Peer Valuation Analysis

Fair Value Range Analysis

Based on median multiples from 7 peer companies in Healthcare

P/E Ratio
$0.00
-100.0%
Peer Median: 0.0x
EV/EBITDA
$0.00
-100.0%
Peer Median: 0.0x
P/S Ratio
$1.78
-56.5%
Peer Median: 8.3x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for KALA's business model and current situation.
Multiple Comparison
MultipleKALA CurrentPeer MedianPeer AveragePremium/DiscountAssessment
P/E Ratio-0.7x0.0x0.0x-Infinity%
Undervalued
EV/EBITDAInfinityx0.0x0.0xInfinity%
Overvalued
P/S Ratio19.2x8.3x7.4x130.1%
Overvalued
Peer Companies
Click any company to view their valuation
CompanyMarket CapP/E RatioEV/EBITDAP/S Ratio
$0.03B0.0x0.0x1.0x
$0.03B0.0x0.0x8.3x
$0.03B0.0x0.0x31.2x
$0.00B0.0x0.0x329.5x
$0.03B0.0x0.0x19.1x
$0.02B0.0x0.0x0.0x
$0.02B0.0x0.0x1.0x